Callan JMB Strengthens Its Market Position with Over-Allotment
SPRING BRANCH, Texas — Callan JMB Inc. (NASDAQ: CJMB), an innovative logistics company dedicated to serving the healthcare sector and emergency management agencies, has announced a partial exercise of the underwriters’ over-allotment option in its initial public offering. This decision resulted in the issuance of an additional 163,569 shares of common stock at a public offering price of $4.00 per share, bringing in further gross proceeds of $654,276. Following this exercise, Callan has successfully issued a total of 1,443,569 shares of common stock, totaling net proceeds of approximately $4,729,319.78 after accounting for underwriting fees and expenses.
Significant Engagement from Underwriters
Leading the underwriting process, Alexander Capital L.P. acted as the managing underwriter and sole book runner for this offering. Supporting them were Paulson Investment Company, LLC, and Bancroft Capital, LLC, who served as co-managers. Legal representation for Callan was provided by Sichenzia Ross Ference Carmel LLP, while Alexander received counsel from Sullivan & Worcester LLP during this important financial maneuver.
Registration and Compliance Measures
A registration statement filed with the U.S. Securities and Exchange Commission on Form S-1 was formally declared effective on February 4, 2025. It’s essential to note that this offering was solely conducted through a prospectus, ensuring compliance and transparency in financial disclosures. Prospective investors are encouraged to read the final prospectus for comprehensive insights regarding the company and the offering.
About Callan JMB: Commitment to Innovation
Callan JMB aims to revolutionize the logistics landscape within the healthcare sector. They provide comprehensive services in fulfillment, storage, monitoring, and cold chain logistics to protect and secure medical materials, ensuring that patients receive compliant and effective medications. With superior expertise in supply chain logistics, regulatory compliance, and emergency preparedness, Callan JMB stands out as a leader in the industry, focused on client satisfaction and environmental sustainability.
Investor Engagement and Communication
Investors can connect with Callan JMB through various channels. Valter Pinto, the Managing Director at KCSA Strategic Communications, is available for inquiries. Investors can reach out via email or phone for further assistance and information regarding the company’s offerings and objectives.
Frequently Asked Questions
What is the recent development announced by Callan JMB?
Callan JMB announced a partial exercise of their underwriters’ over-allotment option during their initial public offering, issuing additional shares.
How many shares were issued in this over-allotment?
An additional 163,569 shares were issued at a public offering price of $4.00 each.
What are the total net proceeds from the IPO?
The total net proceeds from the initial public offering, after expenses, are approximately $4,729,319.78.
Who are the underwriters involved in this IPO?
Alexander Capital L.P. acted as the managing underwriter, with Paulson Investment Company, LLC, and Bancroft Capital, LLC as co-managers.
What services does Callan JMB provide?
Callan JMB specializes in logistics services tailored for the healthcare industry, including fulfillment, storage, monitoring, and cold chain logistics.
